Health Care [ 6/12 ] | Health Care Equipment & Supplies [ 32/75 ]
NASDAQ | Common Stock
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products to treat carotid artery and other vascular diseases in Europe, Latin America, the Middle East, and the Asia Pacific.
The company offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization.
CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard neuroprotection system for flow reversal neuro protection, as well as treating acute stroke with tandem lesions.
It has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions.
The company sells its products through local distribution partners.
InspireMD, Inc. was founded in 2005 and is headquartered in Miami, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Mar 10, 26 | -0.14 Increased by +22.22% | -0.19 Increased by +26.32% |
| Nov 4, 25 | -0.17 Decreased by -4.23% | -0.25 Increased by +32.00% |
| Aug 4, 25 | -0.26 Decreased by -18.18% | -0.21 Decreased by -23.81% |
| May 12, 25 | -0.22 Decreased by -4.76% | -0.20 Decreased by -10.00% |
| Mar 4, 25 | -0.18 Decreased by -12.50% | -0.20 Increased by +7.69% |
| Nov 4, 24 | -0.16 Decreased by -8.73% | -0.20 Increased by +18.45% |
| Aug 5, 24 | -0.22 Increased by +8.33% | -0.19 Decreased by -15.79% |
| May 13, 24 | -0.21 Increased by +60.38% | -0.15 Decreased by -40.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Dec 31, 25 | 3.15 M Increased by +61.57% | -11.76 M Decreased by -28.20% | Decreased by -373.48% Increased by +20.65% |
| Sep 30, 25 | 2.52 M Increased by +39.39% | -12.71 M Decreased by -61.06% | Decreased by -503.69% Decreased by -15.55% |
| Jun 30, 25 | 1.78 M Increased by +2.24% | -13.15 M Decreased by -66.28% | Decreased by -739.65% Decreased by -62.63% |
| Mar 31, 25 | 1.53 M Increased by +1.19% | -11.17 M Decreased by -58.79% | Decreased by -730.28% Decreased by -56.92% |
| Dec 31, 24 | 1.95 M Increased by +10.68% | -9.17 M Decreased by -69.73% | Decreased by -470.70% Decreased by -53.36% |
| Sep 30, 24 | 1.81 M Increased by +16.32% | -7.89 M Decreased by -52.38% | Decreased by -435.91% Decreased by -30.99% |
| Jun 30, 24 | 1.74 M Increased by +5.46% | -7.91 M Decreased by -55.78% | Decreased by -454.80% Decreased by -47.72% |
| Mar 31, 24 | 1.51 M Increased by +21.95% | -7.03 M Decreased by -65.23% | Decreased by -465.39% Decreased by -35.48% |